CIViC Compass
Research use only — not FDA-cleared, not medical advice. Always consult FDA-approved labeling and a qualified clinician.

CIViC Genes

613 genes indexed

CIViC IDGeneEntrez IDDescription
14CDKN2A1029CDKN2A loss has been shown to be a significant event in a number of cancer types. While no targeted therapeutic has been
916CDKN2B1030
927CDX21045
588CEACAM1634
15CEBPA1050'AML with mutated CEBPA' is a provisional entity in the WHO classification of acute myeloid leukemia (AML) and is recomm
7009CFLAR8837
13968CHD857680
981CHEK11111
8950CHEK211200
9326CIC23152
3512CIITA4261
13948CIP2A57650
11781CLDN1851208
56400COX24513
11761CRBN51185
1193CREBBP1387
1204CRKL1399
14303CRLF264109
1234CSF11435
33CSF1R1436
1237CSF2RB1439
1239CSF3R1441
1278CTAG1B1485
11492CTAG230848
8508CTCF10664
1285CTLA41493
1290CTNNB11499
6688CUL38452
7780CUL79820
5167CX3CL16376
3017CXCL103627
6329CXCR47852
1342CYP2D61565
13648CYSLTR257105
10239DAZAP126528
1390DBI1622
1396DCC1630
51DDR24921
1417DDX3X1654
11932DDX4151428
13005DDX4355510
1428DEFA11667
9533DICER123405
9171DKK122943
8524DLL310683
1510DNMT11786
18DNMT3A1788DNMT3A is one of several epigenetic modifiers identified as recurrently mutated in acute myeloid leukemia (AML). DNMT3A
1526DPYD1806
1536DRD51816
11314DROSHA29102
Page 3 of 13 (613 genes)